601607:SSEShanghai Pharmaceuticals Holding Co. Ltd. Class A Analysis
Data as of 2026-09-10 - not real-time
CN¥16.48
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
Shanghai Pharmaceuticals Holding Co., Ltd is priced at ¥16.48 and its moving averages line up in bearish order, the shorter trailing the longer. With RSI at 50.4 the momentum picture is neutral, alongside a bullish MACD signal. Recent trading has carved out support near ¥16.03 and resistance around ¥16.87.
Valuation screens as undervalued: a P/E of 12.8 sits below the sector average of 29.8. Analyst price targets sit 26.4% above the current price. The 2.85% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 15.8%, a beta of 0.08 and a maximum drawdown of 16.9%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 5 out of 10.
Valuation screens as undervalued: a P/E of 12.8 sits below the sector average of 29.8. Analyst price targets sit 26.4% above the current price. The 2.85% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 15.8%, a beta of 0.08 and a maximum drawdown of 16.9%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 5 out of 10.
Top Market Events
Latest Shanghai Pharmaceuticals Holding Co Ltd 601607:SHH.Latest Shanghai Pharmaceuticals Holding Co Ltd 601607:SHH.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 16.97
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 12.8 versus sector average of 29.8
- Trading below the 200-day average of 16.97
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 12.8 versus sector average of 29.8
- Analyst targets imply +26.4% versus the current price
- Dividend yield of 2.85%
Key Metrics & Analysis
Financial Health
Revenue Growth1.90%
Profit Margin1.65%
P/E Ratio12.8
ROE6.96%
ROA2.34%
Debt/Equity63.48
P/B Ratio0.8
Op. Cash FlowCN¥9.6B
Free Cash FlowCN¥1.3B
Industry P/E29.8
Technical Analysis
TrendBearish
RSI50.4
SupportCN¥16.03
ResistanceCN¥16.87
MA 20CN¥16.44
MA 50CN¥16.49
MA 200CN¥16.97
MACDBullish
VolumeDecreasing
Fear & Greed Index92.04
Valuation
Fair ValueCN¥1.21
Target PriceCN¥20.82
Upside/Downside26.35%
GradeUndervalued
TypeValue
Dividend Yield2.85%
Risk Assessment
Beta0.08
Volatility15.75%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.